Zynex, Inc. (ZYXI) P/E Ratio History
Historical price-to-earnings valuation from 2005 to 2024
Loading P/E history...
ZYXI Valuation Context
How does the current P/E compare to historical and market benchmarks?
P/E Ratio Analysis
As of May 8, 2026, Zynex, Inc. (ZYXI) trades at a price-to-earnings ratio of 0.6x, with a stock price of $0.06 and trailing twelve-month earnings per share of $-2.44.
The current P/E is 99% below its 5-year average of 46.3x. Over the past five years, ZYXI's P/E has ranged from a low of 12.6x to a high of 110.3x, placing the current valuation at the 0th percentile of its historical range.
Compared to the Healthcare sector median P/E of 22.3x, ZYXI trades at a 97% discount to its sector peers. The sector includes 241 companies with P/E ratios ranging from 0.0x to 177.5x.
Relative to the broader market, ZYXI trades at a notable discount to the S&P 500 median P/E of 25.1x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our ZYXI DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
ZYXI P/E vs Peers
P/E ratio compared to closely matched public peers
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $4B | 14.9 | - | +56% | |
| $12B | 21.7 | 0.70 | +423%Best | |
| $151B | 11.4Lowest | 0.38Best | +134% | |
| $100B | 21.6 | - | +31% | |
| $84B | 29.2 | - | +55% | |
| $113B | 35.0 | 2.36 | +8% | |
| $8B | 21.6 | 6.84 | +7% |
Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.
ZYXI Historical P/E Data (2005–2024)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Date | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2024 Q4 | $8.01 | $0.09 | 85.9x | +64% | |
| FY2024 Q3 | Mon Sep 30 2024 00:00:00 GM | $8.16 | $0.15 | 55.1x | +5% |
| FY2024 Q2 | Sun Jun 30 2024 00:00:00 GM | $9.32 | $0.17 | 53.7x | +3% |
| FY2024 Q1 | Sun Mar 31 2024 00:00:00 GM | $12.37 | $0.23 | 54.7x | +4% |
| FY2023 Q4 | Sun Dec 31 2023 00:00:00 GM | $10.89 | $0.27 | 40.7x | -22% |
| FY2023 Q3 | Sat Sep 30 2023 00:00:00 GM | $8.00 | $0.43 | 18.5x | -65% |
| FY2023 Q2 | Fri Jun 30 2023 00:00:00 GM | $9.59 | $0.46 | 20.7x | -60% |
| FY2023 Q1 | Fri Mar 31 2023 00:00:00 GM | $12.00 | $0.45 | 26.6x | -49% |
| FY2022 Q4 | Sat Dec 31 2022 00:00:00 GM | $13.91 | $0.44 | 31.4x | -40% |
| FY2022 Q3 | Fri Sep 30 2022 00:00:00 GM | $9.07 | $0.47 | 19.2x | -63% |
| FY2022 Q2 | $7.98 | $0.50 | 15.9x | -70% | |
| FY2022 Q1 | $6.23 | $0.49 | 12.6x | -76% |
Average P/E for displayed period: 52.4x
See ZYXI's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs ZYXI Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare ZYXI vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonZYXI — Frequently Asked Questions
Quick answers to the most common questions about buying ZYXI stock.
Is ZYXI stock overvalued or undervalued?
ZYXI trades at 0.6x P/E, below its 5-year average of 46.3x. At the N/A percentile of historical range, the stock is priced at a discount to its own history.
How does ZYXI's valuation compare to peers?
Zynex, Inc. P/E of 0.6x compares to sector median of 22.3x. The discount suggests lower growth expectations or higher risk.
What is ZYXI's PEG ratio?
ZYXI PEG ratio is N/A. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 2005-2024.